Apriglim-MV 103 Tablet SR
Marketer
Aprica Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Apriglim-MV 103 Tablet SR
Diabetic patients using Glycombo-103 SR tablets, a dual-action antidiabetic medication, should adhere to prescribed dosages. This formulation manages blood glucose in adult type 2 diabetics. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage adjustments are determined by your physician based on blood sugar monitoring. Continuous use, even with controlled blood sugar, is crucial. Discontinuing without medical supervision risks elevated blood glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Carry fast-acting glucose sources (e.g., sugary snacks, juice) to mitigate this. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.
Uses of Apriglim-MV 103 Tablet SR
Managing type 2 diabetes
Major Benefits of Apriglim-MV 103 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Apriglim-MV 103 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
Common Side effects of Apriglim-MV 103 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Apriglim-MV 103 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Apriglim-MV 103 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
How Apriglim-MV 103 Tablet SR works:
The extended-release Apriglim-MV 103 tablet contains a triple-action formulation to manage diabetes.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Apriglim-MV 103 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Apriglim-MV 103 SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Apriglim-MV 103 tablet likely poses a risk to breastfeeding infants. Insufficient human evidence indicates potential drug transfer via breast milk, potentially harming the nursing child.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The extended-release Apriglim-MV 103 tablet carries a high risk of adverse effects in individuals with kidney impairment and its use should be strictly avoided. Medical advice is essential. Furthermore, its administration is contraindicated for patients exhibiting severe renal dysfunction.
LiverCAUTION
Individuals with liver impairment should use Apriglim-MV 103 SR tablets cautiously. Dosage modification of Apriglim-MV 103 SR tablets may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, Apriglim-MV 103 SR tablets are typically initiated at a low dosage; however, their use is contraindicated in patients with severe liver disease.
What if you forget to take Apriglim-MV 103 Tablet SR :
Should you forget a dose of Apriglim-MV 103 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Apriglim-MV 103 Tablet SR
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Diabetes Management |

